20/05/2010 | Adding the hypoxic cytotoxin tirapazamine to chemoradiotherapy does not improve overall survival in unselected patients with advanced head and neack cancer, research shows.
05/02/2010 | Hopes for treating recurrent glioblastoma with enzastaurin - a targeted anti-angiogenic - have been dashed by disappointing phase III study results.
20/11/2009 | Challenging behaviour in brain tumour patients is an under-recognised clinical problem that impacts on both clinicians and carers, a study finds.
20/11/2009 | The classic "brain tumour headache" - there on waking, fading shortly after rising and lasting longer over time - is not a reliable pointer for diagnosis, Australian experts say.
30/10/2009 | Giving chemotherapy at the same time as radiotherapy to patients with locally advanced head and neck cancer who have not had surgery doubles their event free survival, results from the UKHAN1 trial show.
23/09/2009 | The incidence of oesophageal adenocarcinoma is increasing and more support to target risk factors such as smoking and diet is needed to improve survival, Australian researchers conclude.
28/08/2009 | Australian researchers have identified the factors most likely to influence swallowing ability after chemoradiotherapy.
18/08/2009 | Patients with head and neck cancer who experience higher levels of post-treatment pain have a lower chance of survival, a report finds.
04/06/2009 | The addition of bevacizumab to temozolomide and radiation therapy, followed by combination treatment with bevacizumab, temozolomide, and irinotecan, improves progression-free survival at just over one year in almost two-thirds of patients with newly diagnosed glioblastoma multiforme, a small phase II study shows.
29/05/2009 | A 62-year-old Singapore man with metastatic nasopharyngeal carcinoma was temporarily denied entry into the U.S. because the capecitabine he was taking made his fingerprints disappear, according to a letter published in the Annals of Oncology.